Treatment options for tic disorders

被引:9
|
作者
Rizzo, Renata [1 ]
Gulisano, Mariangela [1 ]
机构
[1] Catania Univ, Dept Clin & Expt Med, Child & Adolescent Psychiat Sect, Via Santa Sofia 78, I-95123 Catania, Italy
关键词
Alpha-2; agonists; antipsychotics; tics; Tourette syndrome; vesicular monoamine transporter-2 inhibitors; PLACEBO-CONTROLLED TRIAL; OPEN-LABEL OLANZAPINE; LA-TOURETTE-SYNDROME; DOUBLE-BLIND; 2ND-GENERATION ANTIPSYCHOTICS; PHARMACOLOGICAL-TREATMENT; CHILDREN; ADOLESCENTS; RISPERIDONE; CLONIDINE;
D O I
10.1080/14737175.2020.1698950
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Gilles de la Tourette syndrome (GTS) is a neurodevelopmental disorder, characterized by the presence of multiple motor and, at least one, phonic tics, for more than one year, beginning before 18 years of age; its treatment is often a challenge for the clinician Areas covered: GTS treatment requires a multidisciplinary management to treat each patient's symptom. Although individuals with GTS often have comorbid psychiatric disorders, the focus of this review will only be on the management of tics. Expert opinion: The authors summarized the steps that clinicians should follow treating GTS patient; the impact of the tics on a patients' life should be the first step; different patients could present different levels of tolerance to the symptoms. Second, comorbidities should be considered before starting a treatment for tic. Finally, clinicians must focus the attention of the patient and family, on the length of the treatment and the duration of time after which the effects of the drug will occur. Before the treatment, the potential side effects must be mentioned to the parents, and the choice of treatment must be made in the light of the patient's tolerance to these.
引用
收藏
页码:55 / 63
页数:9
相关论文
共 50 条
  • [1] Pharmacological treatment of tic disorders and Tourette Syndrome
    Roessner, Veit
    Schoenefeld, Katja
    Buse, Judith
    Bender, Stephan
    Ehrlich, Stefan
    Muenchau, Alexander
    NEUROPHARMACOLOGY, 2013, 68 : 143 - 149
  • [2] Therapy of tic disorders
    Roessner, Veit
    Schoenefeld, Katia
    Buse, Judith
    Wanderer, Sina
    Rothenberger, Aribert
    ZEITSCHRIFT FUR KINDER-UND JUGENDPSYCHIATRIE UND PSYCHOTHERAPIE, 2012, 40 (04): : 217 - 236
  • [3] Current pharmacotherapy for tic disorders
    Cothros, Nicholas
    Medina, Alex
    Pringsheim, Tamara
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (05) : 567 - 580
  • [4] Exposure and response prevention versus risperidone for the treatment of tic disorders: a randomized controlled trial
    van de Griendt, Jolande M. T. M.
    Cath, Danielle C.
    Wertenbroek, Agnes A. A. C. M.
    Verdellen, Cara W. J.
    Rath, Judith J. G.
    Klugkist, Irene G.
    de Bruijn, Sebastiaan F. T. M.
    Verbraak, Marc J. P. M.
    FRONTIERS IN PSYCHIATRY, 2025, 15
  • [5] Psychopharmacology of Tic Disorders in Children and Adolescents
    Chadehumbe, Madeline A.
    Greydanus, Donald E.
    Feucht, Cynthia
    Patel, Dilip R.
    PEDIATRIC CLINICS OF NORTH AMERICA, 2011, 58 (01) : 259 - +
  • [6] Current Status, Diagnosis, and Treatment Recommendation for Tic Disorders in China
    Liu, Zhi-Sheng
    Cui, Yong-Hua
    Sun, Dan
    Lu, Qing
    Jiang, Yu-Wu
    Jiang, Li
    Wang, Jia-Qin
    Luo, Rong
    Fang, Fang
    Zhou, Shui-Zhen
    Wang, Yi
    Cai, Fang-Cheng
    Lin, Qing
    Xiong, Lan
    Zheng, Yi
    Qin, Jiong
    FRONTIERS IN PSYCHIATRY, 2020, 11
  • [7] Canadian Guidelines for the Evidence-Based Treatment of Tic Disorders: Pharmacotherapy
    Pringsheim, Tamara
    Doja, Asif
    Gorman, Daniel
    McKinlay, Duncan
    Day, Lundy
    Billinghurst, Lori
    Carroll, Alan
    Dion, Yves
    Luscombe, Sandra
    Steeves, Thomas
    Sandor, Paul
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2012, 57 (03): : 133 - 143
  • [8] Meta-Analysis: Efficacy and Tolerability of Vesicular Monoamine Transporter Type 2 Inhibitors in the Treatment of Tic Disorders
    Behling, Emily
    Farhat, Luis C.
    Landeros-Weisenberger, Angeli
    Bloch, Michael H.
    MOVEMENT DISORDERS, 2022, 37 (04) : 684 - 693
  • [9] Aripiprazole for the treatment of tic disorders in children: a systematic review and meta-analysis
    Yang, Chun-Song
    Huang, Hong
    Zhang, Ling-Li
    Zhu, Cai-Rong
    Guo, Qin
    BMC PSYCHIATRY, 2015, 15
  • [10] Pharmacologic Treatment of Comorbid Attention-Deficit/ Hyperactivity Disorder and Tourette and Tic Disorders
    Jaffe, Robert J.
    Coffey, Barbara J.
    CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2022, 31 (03) : 469 - 477